FR2316943A1 - Pyrrolidones et medicaments qui en contiennent - Google Patents

Pyrrolidones et medicaments qui en contiennent

Info

Publication number
FR2316943A1
FR2316943A1 FR7619563A FR7619563A FR2316943A1 FR 2316943 A1 FR2316943 A1 FR 2316943A1 FR 7619563 A FR7619563 A FR 7619563A FR 7619563 A FR7619563 A FR 7619563A FR 2316943 A1 FR2316943 A1 FR 2316943A1
Authority
FR
France
Prior art keywords
pyrrolidons
products containing
medicinal products
medicinal
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7619563A
Other languages
English (en)
French (fr)
Other versions
FR2316943B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2316943A1 publication Critical patent/FR2316943A1/fr
Application granted granted Critical
Publication of FR2316943B1 publication Critical patent/FR2316943B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7619563A 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent Granted FR2316943A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2316943A1 true FR2316943A1 (fr) 1977-02-04
FR2316943B1 FR2316943B1 (en:Method) 1978-11-03

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7619563A Granted FR2316943A1 (fr) 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent

Country Status (14)

Country Link
JP (1) JPS525764A (en:Method)
AT (1) AT365575B (en:Method)
BE (1) BE843505A (en:Method)
CH (1) CH623809A5 (en:Method)
DE (1) DE2528664A1 (en:Method)
DK (1) DK287476A (en:Method)
ES (1) ES449095A1 (en:Method)
FR (1) FR2316943A1 (en:Method)
GB (1) GB1553595A (en:Method)
IL (1) IL49916A0 (en:Method)
LU (1) LU75235A1 (en:Method)
NL (1) NL7606773A (en:Method)
SE (1) SE7607331L (en:Method)
ZA (1) ZA763802B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2369260A1 (fr) * 1976-08-06 1978-05-26 Pfizer 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
CN1413190A (zh) * 1999-12-22 2003-04-23 辉瑞产品公司 治疗骨质疏松的ep4受体选择性激动剂
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
PT1339678E (pt) 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
RU2288913C2 (ru) 2001-07-16 2006-12-10 Ф.Хоффманн-Ля Рош Аг Аналоги простагландинов, способ их получения и фармацевтическая композиция, обладающая селективной агонистической активностью в отношении рецептора ep4
JP4211605B2 (ja) 2001-07-16 2009-01-21 小野薬品工業株式会社 プロスタノイドアゴニストとしての２ピロリドン誘導体
IL159996A0 (en) 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
EP1487437B1 (en) * 2002-03-18 2006-08-16 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of diseases
US6573294B1 (en) 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
JP2006515015A (ja) 2003-01-10 2006-05-18 エフ．ホフマン−ラ　ロシュ　アーゲー プロスタグランジンアゴニストとしての２−ピペリドン誘導体
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
CA2879507A1 (en) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
US9914725B2 (en) 2013-03-15 2018-03-13 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
ES2635635T3 (es) 2013-03-15 2017-10-04 Cayman Chemical Company, Incorporated Compuestos de difluorolactama como agonistas selectivos del receptor EP4 para su uso en el tratamiento de enfermedades y afecciones mediadas por EP4
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOLUME 85 1976 123 751 H CITE JA - A - 76 01 461 TANABE SEIYAKU CO. ) *
TETRAHEDRON LETTERS, NO. 51 1975 , PAGES 4599 - 4602 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2369260A1 (fr) * 1976-08-06 1978-05-26 Pfizer 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation

Also Published As

Publication number Publication date
IL49916A0 (en) 1976-08-31
DK287476A (da) 1976-12-28
DE2528664A1 (de) 1977-01-13
CH623809A5 (en) 1981-06-30
NL7606773A (nl) 1976-12-29
JPS525764A (en) 1977-01-17
FR2316943B1 (en:Method) 1978-11-03
SE7607331L (sv) 1976-12-28
ZA763802B (en) 1977-05-25
ATA467976A (de) 1981-06-15
AT365575B (de) 1982-01-25
BE843505A (fr) 1976-12-28
ES449095A1 (es) 1977-12-16
GB1553595A (en) 1979-09-26
LU75235A1 (en:Method) 1977-03-16

Similar Documents

Publication Publication Date Title
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
BE860877A (fr) Spirolactones steroidiques et medicaments qui en contiennent
FR2282892A1 (fr) Derives de la purine et medicaments qui en contiennent
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
BE865870A (fr) Derives du benzimidazole et medicaments qui en contiennent
FR2316943A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2312240A1 (fr) Derives du prostane et medicaments qui en contiennent
FR2326927A1 (fr) Steroides insatures en 15 et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
FR2342990A1 (fr) Androstenones et medicaments qui en contiennent
FR2287224A1 (fr) Derives de la pyridine et medicaments qui en contiennent
DK194776A (da) Antibakterielle midler og mellemprodukter dertil
FR2287908A1 (fr) Hydroxy-7 oestradiols et medicaments qui en contiennent
BE849346R (fr) Pyrrolidones et medicaments qui en contiennent
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
FR2316941A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
BE788322A (fr) 3,4-dihydro-2h-isoquinoleine-1-ones et medicaments qui en contiennent
FR2347925A1 (fr) Medicaments, cosmetiques et pesticides renfermant des fluoroacyl-resorcines
BE833065A (fr) Homo-steroides et medicaments qui en renferment
BE843351A (fr) Pyrrolidones et medicaments qui en contiennent
FR2313066A1 (fr) Oxadiazines et medicaments qui en contiennent
BE857535A (fr) Nouvelles organoprostaglandines et medicament les contenant
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant

Legal Events

Date Code Title Description
ST Notification of lapse